|
Immunity & Ageing 2011
The "Alzheimer's disease signature": potential perspectives for novel biomarkersAbstract: Alzheimer's disease (AD) is the most common form of dementia and age-dependent neurodegenerative disorder. It represents one of the major public health problems in our modern age and epidemiological investigations estimated that the amount of people with AD will rise to over 100 million by 2050 [1]. The main hallmarks of the disease are decreased number of neurons, formation of amyloid plaques and generation of neurofibrillary tangles which results in neuronal dysfunction. Although a definitive diagnosis of AD is not possible until autopsy, diagnostic tools to detect AD have improved considerably in recent years. Even though there was significant technological advance, improved antemortem AD diagnostic methods are still needed. To date, early diagnosis of AD is difficult, therefore an important challenge for the successful management of AD is the development of new tools to detect AD in its earliest stages which could predict the progression of the disease. In addition, it is necessary to translate neurobiological knowledge and biomarker research into clinical practice. In this perspective, there is a significant effort to discover novel candidate biomarkers that together with those well established will be able to improve the accuracy of diagnosis. Fortunately, there has been a significant progress toward the use of potent and modern methods which allow the concomitant measurement of several biomarkers but we are far to define and create a reliable diagnostic and prognostic profile.According to the National Institute of Health, a biomarker is "a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention" [2].Nowadays there is still not an ideal biomarker able to improve differential diagnosis, track disease progression and measure treatment efficacy. This means that we have an urgent need to develop biomarkers that are sensitive and specific t
|